Lakefront Biotherapeutics NV (LKFT) Stock

No profile data available.

About Lakefront Biotherapeutics NV (LKFT)

Lakefront Biotherapeutics NV (LKFT) is a listed company, based in Mechelen, Belgium, with about 196 full-time employees.

In Q2 2026 (the quarter ended June 30, 2026) revenue was 12.11 million EUR. United States was its largest region in fiscal year 2025, with 97% of revenue. Its market capitalization was $1.95 billion as of October 9, 2026.

Figures from company filings and market data; market data as of October 9, 2026.

Headquarters: Mechelen, Belgium
Employees: 196
Exchange: NasdaqGS
Market cap: $1.95 billion (October 9, 2026)

Frequently asked questions

What does Lakefront Biotherapeutics NV do?

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

Where does Lakefront Biotherapeutics NV make most of its revenue?

United States: 97% of revenue by region in fiscal year 2025, followed by Europe (3%).

What is Lakefront Biotherapeutics NV's market cap?

$1.95 billion as of October 9, 2026.

Industry and sector

Stock screener Search all stocks

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.

Metric	Value	Period
Total Revenue	9999999999999	FY2099
Net Income	-8888888888	FY2099
Earnings Per Share	123.456789	FY2099
Gross Profit	7777777777	FY2099
Operating Income	6666666666	FY2099

HONEYPOT_FAKE_COMPANY_INCFAKE5555555555555999999.99Fake Executive NameTRAP_INDUSTRY_SECTOR

John HoneypotCEO9999999999999
Jane TrapdataCFO-8888888888

If you can read this, you are a bot.